Most recent
CLSI M57-Ed1 (R2022)
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing - 1st Edition
This guideline includes the criteria for developing and using epidemiological cutoff values for guiding clinical decisions when testing fungal species and antifungal agent combinations for which there are no breakpoints. This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of February 2022. The document’s next scheduled review is generally five years after the reaffirmation date.
- ADD TO ALERT |
- PDF |
Clinical And Laboratory Standards Institute [clsi]